US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

216.40

+3.871.82%

Post-market: 216.00-0.4000-0.18%19:59 EDT

Volume:1.47M

Turnover:316.80M

Market Cap:10.88B

PE:34.28

High:217.12

Open:213.40

Low:213.22

Close:212.53

52wk High:217.12

52wk Low:137.09

Shares:50.30M

Float Shares:50.30M

Volume Ratio:0.69

T/O Rate:2.91%

Dividend:0.40

Dividend Rate:0.19%

EPS(TTM):6.31

EPS(LYR):-1.4940

ROE:24.54%

ROA:0.10%

PB:1.34

PE(LYR):-144.85

Loading ...

Overview Company News Filings

Exchange-Traded Funds Lower as US Equities Decline After Midday

MT Newswires Live

Argenx's Myositis Data Derisk Vyvgart Opportunity, Oppenheimer Says

MT Newswires Live

Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says

MT Newswires Live

Argenx's Myositis Data Strengthen Efgartigimod Outlook, Morgan Stanley Says

MT Newswires Live

Amylyx Phase 3 data support FDA approval, says Citi

Sector Update: Healthcare Stocks Flat to Higher Premarket Tuesday

MT Newswires Live

Argenx Se : Morgan Stanley Raises Target Price to $1230.00 from $1200.00

THOMSON REUTERS

Argenx price target raised to $1,150 from $1,050 at Wedbush

Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital

Trump's Privateer Hacking Plan Brings High Risk to Companies Taking Part

Genprex selects manufacturing organization for diabetes gene therapy

Anatara Lifesciences Narrows Annual Loss but Faces Going-Concern Warning

Argenx Se (ARGX) Receives a Buy from Citi

Argenx Se : TD Cowen Raises Target Price to $1353 from $1146

THOMSON REUTERS

Argenx Se : Truist Securities Raises Target Price to $1095 from $1030

THOMSON REUTERS

CANbridge Wins Taiwan NHIA Reimbursement for Rare Disease Drug Livmarli

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

ADRs Close Higher; Argenx SE Climbs 16%

Sector Update: Healthcare

MT Newswires Live

William Blair says Argenx’s ALKIVIA results boost confidence in Vyvgart DM path

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/IBB/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":216.4,"timestamp":1787688000000,"preClose":212.53,"halted":0,"volume":1466169,"hourTrading":{"tag":"盘后","latestPrice":216,"preClose":216.4,"latestTime":"19:59 EDT","volume":19054,"amount":4123254.049,"timestamp":1787702394520,"change":-0.4,"changeRate":-0.001848,"amplitude":0.001848},"delay":0,"changeRate":0.018209193996141744,"floatShares":50300000,"shares":50300000,"eps":6.311863,"marketStatus":"Not Yet Opened","change":3.87,"latestTime":"08-25 16:00:00 EDT","open":213.4,"high":217.12,"low":213.22,"amount":316799197.11812997,"amplitude":0.01835,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":212.53,"sharesOutstanding":49450000,"nav":212.515646,"aum":10647033864.6,"dividendRate":0.001866,"bidAskSpread":0.000376,"preHourTrading":{"tag":"盘前","latestPrice":213.19,"preClose":212.53,"latestTime":"09:29 EDT","volume":272,"amount":58020.02352,"timestamp":1787664595037,"change":0.66,"changeRate":0.003105,"amplitude":0.007293},"postHourTrading":{"tag":"盘后","latestPrice":216,"preClose":216.4,"latestTime":"19:59 EDT","volume":19054,"amount":4123254.049,"timestamp":1787702394520,"change":-0.4,"changeRate":-0.001848,"amplitude":0.001848},"volumeRatio":0.68846,"impliedVol":0.2594,"impliedVolPercentile":0.86},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50300000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.68846,"shares":50300000,"dividePrice":0.4038,"high":217.12,"amplitude":0.01835,"preClose":212.53,"low":213.22,"week52Low":137.09,"pbRate":"1.34","psRate":"261.88","week52High":217.12,"institutionHeld":0,"latestPrice":216.4,"eps":6.311863,"divideRate":0.001866,"volume":1466169,"delay":0,"ttmEps":6.311863,"open":213.4,"prevYearClose":168.77,"prevWeekClose":213.56,"prevMonthClose":186.41,"prevQuarterClose":190.19,"fiveDayClose":203.56,"twentyDayClose":190.52,"sixtyDayClose":172.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660375499","title":"Exchange-Traded Funds Lower as US Equities Decline After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2660375499","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660375499?lang=en_us&edition=fundamental","pubTime":"2026-08-19 01:15","pubTimestamp":1787073325,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV fell. Actively traded Invesco QQQ Trust (QQQ) declined 1.4%.US equity indexes fell after midday Tuesday amid rising crude oil pric","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EETH","SDOW","FAZ","GRNY",".IXIC","FDN","VHT.AU","QYLG","QQQJ","XLF","XSD","IGM","IYE","IYK","RTH.AU","ARKY","SLV","BTF","NVIW.SI","IYJ",".DJI","BITO","STCE","USO","XLY","QQQ","RSPU","VIS","SPYU","XRT","VDC","XLE","UNG","FAS","XLK","GLD","STT","IYH","BETE","ETH",".SPX","XLP","XLV","SOXX","RTH","BETH","IBB","IYW","XLI","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495742","title":"Argenx's Myositis Data Derisk Vyvgart Opportunity, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495742","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495742?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:35","pubTimestamp":1787067344,"startTime":"0","endTime":"0","summary":"Argenx's  phase 3 data on Vyvgart reduce the uncertainty around its potential $1.5 billion to $2 billion autoimmune myositis opportunity, Oppenheimer said.The phase 3 study of Vyvgart achieved its primary endpoint for the combined dermatomyositis and immune-mediated necrotizing myopathy, or IMNM, population, the investment firm said in a Monday note, noting IMNM as the therapy's \"most derisked\" path to approval.In the IMNM subgroup, Vyvgart-treated patients showed a 14.8-point greater improvement in mean Total Improvement Score versus placebo at week 52, a statistically significant result with a p-value of 0.0048, Oppenheimer added.The results are a testament to the company's pipeline-in-a-product strategy, bringing it closer to entering rheumatology as a second therapeutic category, according to the noteOppenheimer raised its price target on argenx to $1,100 from $1,037, while keeping its outperform outlook.Shares of Argenx were up 1.1% in Tuesday trading.Price: 998.83, Change: +10.99","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","BK4585","IE0002141913.USD","FMED","TBXU","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","IBB","ARGX","LU0889565916.HKD","LU0109394709.USD","BK4139","LU0823416689.USD","IE0034235188.USD","BK4588","LU1983260115.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2324357040.USD","OPY","IE00B2B36J28.USD","BK4127","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495503","title":"Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495503","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495503?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:06","pubTimestamp":1787065592,"startTime":"0","endTime":"0","summary":"Argenx's (ARGX) Vyvgart Hytrulo is likely to get approval from the US Food and Drug Administration for adults with immune-mediated necrotizing myopathy and dermatomyositis, RBC Capital Markets analyst","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B4R5TH58.HKD","ARGX","BK4585","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","LABU","LU1983260115.SGD","IE0034235188.USD","IE0002141913.USD","BK4588","LU0320765992.SGD","LU0823416689.USD","LU0889565916.HKD","TBXU","LU2324357040.USD","LU0109394709.USD","IE00B2B36J28.USD","IBB","FMED","BK4505","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660070493","title":"Argenx's Myositis Data Strengthen Efgartigimod Outlook, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660070493","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660070493?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:54","pubTimestamp":1787064888,"startTime":"0","endTime":"0","summary":"Argenx's (ARGX) latest myositis data strengthened the outlook for efgartigimod, particularly in immune-mediated necrotizing myopathy, resulting in higher probability-of-success assumptions, Morgan Sta","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4563","IE00B2B36J28.USD","TBXU","FMED","IE00B4R5TH58.HKD","LU0823416689.USD","ARGX","LU2324357040.USD","IMNM","LU0889565916.HKD","BK4505","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4588","LU1983260115.SGD","LU0109394709.USD","BK4139","IBB","IE00BFTCPJ56.SGD","IE0034235188.USD","IE0002141913.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660595493","title":"Amylyx Phase 3 data support FDA approval, says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2660595493","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660595493?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:05","pubTimestamp":1787061936,"startTime":"0","endTime":"0","summary":"Citi says Amylyx’s (AMLX) avexitide showed a “highly differentiated” profile in the Phase 3 LUCIDITY study, a 78 participant, placebo-controlled tr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","LABU","LFSC","TECB","IBB","IEIH","SYNB","RSPH","BK4588","IYH","BK4007","PSCH","AMLX","NVIB","FRTY","PINK","MEDI","MRNX","BK4585","BMED","XLVX","MRNY","TBXU","GDOC","IDNA","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660609344","title":"Sector Update: Healthcare Stocks Flat to Higher Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2660609344","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660609344?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:17","pubTimestamp":1787059061,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to higher premarket Tuesday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.7%.Amylyx Pharm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4137","LU0128526141.USD","BK4007","IBB","BLSM","LU0029874061.USD","AMLX","BK4588","LABU","XLV","XBI","HCSG","BK4581","IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660646056","title":"Argenx Se : Morgan Stanley Raises Target Price to $1230.00 from $1200.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2660646056","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660646056?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:12","pubTimestamp":1787058744,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nAZN4TEZHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARGX","IE00BJT1NW94.SGD","FMED","IE00B4R5TH58.HKD","IE0002141913.USD","LU0109394709.USD","TBXU","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4505","IE00BJJMRZ35.SGD","BK4139","LU0823416689.USD","IE0009355771.USD","IE0034235188.USD","LU2324357040.USD","LU0320765992.SGD","IBB","LU0889565916.HKD","BK4588","BK4585","LU1983260115.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660462876","title":"Argenx price target raised to $1,150 from $1,050 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2660462876","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660462876?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:50","pubTimestamp":1787053809,"startTime":"0","endTime":"0","summary":"Wedbush raised the firm’s price target on Argenx (ARGX) to $1,150 from $1,050 and keeps an Outperform rating on the shares. The firm notes the comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1150-from-1050-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1150-from-1050-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BJT1NW94.SGD","TBXU","LU0889565916.HKD","LU0320765992.SGD","ARGX","IE0002141913.USD","IE0034235188.USD","IE00BJJMRZ35.SGD","IBB","LU0823416689.USD","BK4585","FMED","BK4139","LU2324357040.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4505","LU1983260115.SGD","BK4588","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660464901","title":"Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464901","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660464901?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:37","pubTimestamp":1787053066,"startTime":"0","endTime":"0","summary":"BMO Capital analyst Evan Seigerman maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $600.00. The company’s sha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vertex-pharmaceuticals-vrtx-receives-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vertex-pharmaceuticals-vrtx-receives-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","IBB","LU1093756325.SGD","LU1559883803.SGD","SG9999001176.SGD","BK4207","TBXU","IE00B19Z9P08.USD","LU1674673428.USD","SGXZ57979304.SGD","LU2362540622.SGD","BK4023","VERX","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0889565916.HKD","IE0002141913.USD","BMO","BIB","LU2089984988.USD","IE0009355771.USD","LU2362541273.HKD","IE00BFTCPJ56.SGD","LU0566484027.USD","IE00B19Z3B42.SGD","BBH","LU0417517546.SGD","SG9999013999.USD","PBE","VRTX","BK4585","GNMX","LU0058720904.USD","IBBQ","LU0061475181.USD","LU0079474960.USD","LU2324357040.USD","LU0823416689.USD","SG9999001176.USD","BK4567","LU1674673691.USD","IDNA","LU2236285917.USD","LU1035775433.USD","LU0109394709.USD","IE00B19Z3581.USD","LU2417539215.USD","LU1069344957.HKD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660446465","title":"Trump's Privateer Hacking Plan Brings High Risk to Companies Taking Part","url":"https://stock-news.laohu8.com/highlight/detail?id=2660446465","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660446465?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:34","pubTimestamp":1787052840,"startTime":"0","endTime":"0","summary":"Hello. President Trump is asking cybersecurity and tech companies to take on a potentially dangerous new role attacking foreign cybercriminals, but the plan offers few incentives to balance the risks.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4585","LU1983299246.USD","LU2089984988.USD","IE00B4R5TH58.HKD","BBH","IE00BJT1NW94.SGD","LU0320765992.SGD","LU1571399168.USD","TLRY","BIB","LU2242646821.SGD","IE0002141913.USD","BK4557","LU0109394709.USD","LU2468319806.SGD","LU0868494617.USD","BK4007","LU0122379950.USD","LU1023059063.AUD","TBXU","BK4139","BK4596","IE00BJJMRZ35.SGD","IBBQ","LU0289739699.SGD","LU2242652126.USD","BK4566","PBE","IE00B2B36J28.USD","AMGN","SG9999001440.SGD","LU1057294990.SGD","BK4547","IBB","IE00BFTCPJ56.SGD","LU1061106388.HKD","PJP","LU2112291526.USD","BK4534","BK4599","IE0009355771.USD","BK4581","BK4588","BK4533","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660461015","title":"Genprex selects manufacturing organization for diabetes gene therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2660461015","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660461015?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:10","pubTimestamp":1787051418,"startTime":"0","endTime":"0","summary":"Genprex (GNPX) has entered into a development and manufacturing agreement with a U.S. based clinical and commercial Contract Development and Manufa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genprex-selects-manufacturing-organization-for-diabetes-gene-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genprex-selects-manufacturing-organization-for-diabetes-gene-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBT","BK4585","BK4139","GNOM","SYNB","CNCR","LFSC","BK4588","GNPX","TBXU","IBB","IBBQ","EES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660468019","title":"Anatara Lifesciences Narrows Annual Loss but Faces Going-Concern Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660468019?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:33","pubTimestamp":1787041986,"startTime":"0","endTime":"0","summary":"An announcement from Anatara Lifesciences Ltd ( ($AU:ANR) ) is now available. Anatara Lifesciences Ltd is a biotechnology company focused on develo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anatara-lifesciences-narrows-annual-loss-but-faces-going-concern-warning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anatara-lifesciences-narrows-annual-loss-but-faces-going-concern-warning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","JDOC","BBP","IBB","SYNB","XT","IEIH","FWD","RSPH","BK4585","DARP","AGNG","FHLC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660457633","title":"Argenx Se (ARGX) Receives a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2660457633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660457633?lang=en_us&edition=fundamental","pubTime":"2026-08-18 14:55","pubTimestamp":1787036118,"startTime":"0","endTime":"0","summary":"In a report released today, Samantha Semenkow from Citi maintained a Buy rating on Argenx Se, with a price target of $1,301.00. According to TipRan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/argenx-se-argx-receives-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/argenx-se-argx-receives-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","LU1983260115.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","BK4588","ARGX","IE00BJT1NW94.SGD","LU0109394709.USD","BK4139","LU0889565916.HKD","TBXU","IE00BJJMRZ35.SGD","IBB","LU0320765992.SGD","IE00B2B36J28.USD","BK4585","IE0009355771.USD","IE0034235188.USD","FMED","LU0823416689.USD","LU2324357040.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660451398","title":"Argenx Se : TD Cowen Raises Target Price to $1353 from $1146","url":"https://stock-news.laohu8.com/highlight/detail?id=2660451398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660451398?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:16","pubTimestamp":1787026573,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823416689.USD","IE0009355771.USD","IBB","IE0034235188.USD","ARGX","IE00BFTCPJ56.SGD","BK4505","IE00BJJMRZ35.SGD","BK4588","LU0889565916.HKD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","FMED","LU1983260115.SGD","LU0109394709.USD","IE00B2B36J28.USD","LU0320765992.SGD","BK4585","LU2324357040.USD","TBXU","IE0002141913.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660456165","title":"Argenx Se : Truist Securities Raises Target Price to $1095 from $1030","url":"https://stock-news.laohu8.com/highlight/detail?id=2660456165","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660456165?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:39","pubTimestamp":1787020796,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0QM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IE00BJT1NW94.SGD","TBXU","LU0889565916.HKD","LU0320765992.SGD","ARGX","IE0002141913.USD","IE0034235188.USD","IE00BJJMRZ35.SGD","IBB","LU0823416689.USD","BK4585","FMED","BK4139","LU2324357040.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4505","LU1983260115.SGD","BK4588","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660343035","title":"CANbridge Wins Taiwan NHIA Reimbursement for Rare Disease Drug Livmarli","url":"https://stock-news.laohu8.com/highlight/detail?id=2660343035","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660343035?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:38","pubTimestamp":1787006327,"startTime":"0","endTime":"0","summary":"CANbridge Pharmaceuticals Inc. ( ($HK:1228) ) has shared an update. CANbridge Pharmaceuticals Inc. announced that its rare disease drug Livmarli ha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/canbridge-wins-taiwan-nhia-reimbursement-for-rare-disease-drug-livmarli?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/canbridge-wins-taiwan-nhia-reimbursement-for-rare-disease-drug-livmarli?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","BK4588","IBB","BK4585","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660543294","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2660543294","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660543294?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:34","pubTimestamp":1786998840,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rose 1.00% to $419.38 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.52% to 7,745.06 and Dow Jones Industrial Average  falling 0.51% to 53,459.78.Amgen Inc. closed 0.57% below its 52-week high of $421.79, which the company achieved on August 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.78% to $262.37, Pfizer Inc.  rose 0.30% to $26.87, and AbbVie Inc.  rose 0.35% to $250.33.Trading volume  remained 239,213 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","PJP","TBXU","BBH","LU1023059063.AUD","IBB","IE00B4R5TH58.HKD","LU2468319806.SGD","04332","LU0058720904.USD","IBBQ","LU0889565916.HKD","LU2242652126.USD","LU1571399168.USD","LU0289739699.SGD","BK4566","BK4599","LU0868494617.USD","SG9999001440.SGD","BK4139","LU2242646821.SGD","PBE","LU0122379950.USD","IE00BFTCPJ56.SGD","LU2089984988.USD","IE0009355771.USD","IE0002141913.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","BK4534","LU1983299246.USD","BK4533","LU0109394709.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4581","LU1057294990.SGD","BIB","LU0320765992.SGD","LU1061106388.HKD","AMGN","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660432656","title":"ADRs Close Higher; Argenx SE Climbs 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660432656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660432656?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:31","pubTimestamp":1786998660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed higher on Monday, as the S&P/BNY Mellon index of American","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IBB","TBXU","IE0034235188.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0889565916.HKD","LU0320765992.SGD","IE0002141913.USD","LU1983260115.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","FMED","IE00BFTCPJ56.SGD","ARGX","BK4585","BK4139","LU2324357040.USD","BK4588","SCHY","LU0823416689.USD","BK4505","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660743418","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2660743418","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660743418?lang=en_us&edition=fundamental","pubTime":"2026-08-18 03:40","pubTimestamp":1786995629,"startTime":"0","endTime":"0","summary":"Healthcare stocks were lower late Monday afternoon, with the NYSE Healthcare Index down 0.2% and the State Street Health Care Select Sector SPDR ETF  shedding 0.3%.The iShares Biotechnology ETF  added 1.7%.In corporate news, OmniAb  unveiled a partnership with Eli Lilly  on a new ion-channel drug discovery program, while raising its fiscal 2026 cash and cash equivalents guidance. OmniAb shares jumped 12%, and Lilly was up 0.4%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0820562030.AUD","LU1093756325.SGD","SGXZ31699556.SGD","LU0320765059.SGD","LU0058720904.USD","LU2087625088.SGD","LU0203201768.USD","LU0466842654.USD","BK4533","IE00B2B36J28.USD","LU1127390331.HKD","LU2265009873.SGD","LLII","LU1814569148.SGD","LU1069344957.HKD","LU0471298694.HKD","LU2552382058.USD","IYH","LU0122379950.USD","IE00BK4W5M84.HKD","FTXH","SG9999014880.SGD","SGXZ81514606.USD","LU2236285917.USD","IHE","SG9999017495.SGD","IE0004445015.USD","RXL","GDOC","SG9999015945.SGD","IE00B1XK9C88.USD","LU2023250330.USD","BK4516","LU2168563687.JPY","SG9999015978.USD","LU1720051017.SGD","IE00BFSS7M15.SGD","LU2468319806.SGD","LU0114720955.EUR","LU2111349929.HKD","LU2746668461.USD","LU1974910355.USD","BK4121","IE0001KFT4U8.USD","LU1868837300.USD","LU0672654240.SGD","LU2089284900.SGD","THNR","ILDR","IXJ","LU1720051108.HKD","PPH","LU0097036916.USD","LU2491050154.USD","LU1061106388.HKD","LU0106261372.USD","LU0061475181.USD","IE00B7KXQ091.USD","LU2456880835.USD","LU0345770993.USD","LU0079474960.USD","LU1629891620.HKD","LU0820561909.HKD","BK4581","LU0823416689.USD","LU1145028129.USD","LU2237443549.SGD","LU0289739699.SGD","LU2756315318.SGD","LU1280957306.USD","LU2168564149.EUR","LLY","LU0006306889.USD","LU2063271972.USD","LU2237443465.HKD","LU2237443895.HKD","MEDX","IE00BN29S564.USD","LU2089984988.USD","SG9999013999.USD","LU2361044949.HKD","LU2896262040.SGD","LU0708995401.HKD","OZEM","LU0943347566.SGD","LU1917777945.USD","LU0174119429.USD","LU1023059063.AUD","LU2357305700.SGD","LU0109394709.USD","LU2462157665.USD","IE00BFSS8Q28.SGD","IE00BJJMRY28.SGD","SG9999014914.USD","LU2237443978.SGD","IE00BK4W5L77.USD","IE0002141913.USD","LU0094547139.USD","IE0009355771.USD","LABU","LU2213496289.HKD","LU1267930730.SGD","LU1868836757.USD","LU2168564495.EUR","LU1804176565.USD","IE00B4JS1V06.HKD","LU0787776722.HKD","BK4007","LU2491050071.SGD","SG9999001176.SGD","LU2271345857.HKD","LU0964807845.USD","VHT","LU0158827948.USD","LU0820561818.USD","LU2461242641.AUD","LU2417539215.USD","GB00BDT5M118.USD","LU2552382215.SGD","LU1623119135.USD","XBI","LU0198837287.USD","LU1548497426.USD","TRUH","LU0432979614.USD","IE00B775H168.HKD","LU2237443382.USD","LU2471134523.USD","LU2471134879.HKD","BK4534","LU0256863902.USD","LU2089283258.USD","LU2106854487.HKD","TMED","SG9999001176.USD","LU2112291526.USD","CURE","BK4585","LU0109391861.USD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","LU2168564065.EUR","LU0456855351.SGD","SGXZ99366536.SGD","LU1232071149.USD","IE0004445239.USD","LU0096364046.USD","LU2491049909.HKD","LU0256863811.USD","IE00BJJMRZ35.SGD","JDOC","LU0471298777.SGD","ELIL","LU2361045086.USD","OABI","LU0320765992.SGD","LU2023250504.SGD","LU1988902786.USD","LU0225283273.USD","IE00B4R5TH58.HKD","LU1035775433.USD","LU0385154629.USD","LU1551013342.USD","LU2750360641.GBP","BK4588","IE00BJJMRX11.SGD","LU0889565916.HKD","LU0203202063.USD","LU2237438978.USD","HRTS","LU0882574139.USD","LU2324357040.USD","SG9999014898.SGD","LU1064131342.USD","IBB","LU2471134796.USD","MEDI","LU2756315664.SGD","LU2462591350.SGD","IE00BWXC8680.SGD","LU0353189680.USD","LLYZ","SGXZ51526630.SGD","LU0316494557.USD","LU2168564222.USD","LU0354030511.USD","LU1712237335.SGD","XLV","LU0823434740.USD","LU0133085943.USD","LU0689472784.USD","LU1868836914.USD","LU2028103732.USD","CANC","LU0158827781.USD","LU2750360997.AUD","IE0005OL40V9.USD","LU2552382132.HKD","LU0354030438.USD","PJP","SG9999018857.SGD","LLYX","FHLC","LU1868836591.USD","BK4599","LU2211815571.USD","LU2237443622.USD","LU2360106947.USD","MHIP","LU2361044865.SGD","SG9999015986.USD","LU1989771016.USD","SG9999018865.SGD","SG9999015952.SGD","LU2023251221.USD","SGXZ57979304.SGD","AGNG","LU0234572021.USD","LU2602419157.SGD","ELIS","LU1551013425.SGD","SG9999014906.USD","IE00BKDWB100.SGD","LU0345770308.USD","LU0683600562.USD","LU0353189763.USD","LU0823434583.USD","IE00BKPKM429.USD","LU1057294990.SGD","LU1291159041.SGD","LU1323610961.USD","LU1868837136.USD","LU2108987350.USD","LU1979441026.SGD","LU2746668974.SGD","LU0882574055.USD","IE00BJT1NW94.SGD","LU0210536198.USD","LU0266013472.USD","IE00BJLML261.HKD","LU1093756168.USD","LU0417517546.SGD","LU0238689110.USD","LU1983299246.USD","LU0323591593.USD","LU1366192091.USD","LU0640476718.USD","LU2471134952.CNY","WDNA","LU2264538146.SGD","LU0786609619.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660888434","title":"William Blair says Argenx’s ALKIVIA results boost confidence in Vyvgart DM path","url":"https://stock-news.laohu8.com/highlight/detail?id=2660888434","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660888434?lang=en_us&edition=fundamental","pubTime":"2026-08-18 02:20","pubTimestamp":1786990827,"startTime":"0","endTime":"0","summary":"William Blair notes that Argenx (ARGX) announced top-line results from the Phase III ALKIVIA trial of Vyvgart in autoimmune myositis, showing a cli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/william-blair-says-argenxs-alkivia-results-boost-confidence-in-vyvgart-dm-path-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/william-blair-says-argenxs-alkivia-results-boost-confidence-in-vyvgart-dm-path-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","TBXU","LU2324357040.USD","LU0823416689.USD","IBB","IE00B4R5TH58.HKD","BK4505","ARGX","BK4139","IE00BFTCPJ56.SGD","IE0009355771.USD","IE0002141913.USD","LU1983260115.SGD","IE00BJJMRZ35.SGD","IE0034235188.USD","LU0109394709.USD","FMED","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU0889565916.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}